statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

HC Wainwright reaffirmed their neutral rating on shares of 60 Degrees Pharmaceuticals (NASDAQ:SXTP - Free Report) in a research report released on Wednesday morning, Benzinga reports. HC Wainwright...

60 Degrees Pharmaceuticals (NASDAQ:SXTP) Rating Reiterated by HC Wainwright

See the rest of the story here.

thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

60 Degrees Pharmaceuticals to sponsor pilot study of tafenoquine

Study to be conducted by North Carolina State University in 2024Standard of care fails in 20 percent of cases and drug resistance is a problemStandard of care is expensive WASHINGTON, April 03...

60 Degrees Pharmaceuticals to Sponsor Pilot Study of Tafenoquine for Treatment of Canine Babesiosis

60 Degrees Pharmaceuticals, Inc. (NASDAQ:SXTP  Get Free Report) was the target of a significant drop in short interest in March. As of March 15th, there was short interest totalling 65,500...

Short Interest in 60 Degrees Pharmaceuticals, Inc. (NASDAQ:SXTP) Decreases By 56.9%

Central Bank & Trust Co. reduced its position in 60 Degrees Pharmaceuticals, Inc. (NASDAQ:SXTP  Free Report) by 23.7% in the 4th quarter, according to the company in its most recent Form 13F...

60 Degrees Pharmaceuticals, Inc. (NASDAQ:SXTP) Stock Holdings Trimmed by Central Bank & Trust Co.

WASHINGTON, March 14, 2024 (GLOBE NEWSWIRE) -- 60 Degrees Pharmaceuticals, Inc., (NASDAQ: SXTP, SXTPW) ( 60 Degrees Pharmaceuticals or the Company ), a pharmaceutical company focused on...

60 Degrees Pharmaceuticals Announces Communication from the FDA of Intention to Respond to Tafenoquine-Babesiosis Trial Protocol Submission in April, 2024

Candida auris (C. auris) is a dangerous drug-resistant fungal pathogen emerging in U.S. hospitalsTafenoquine's presumed mode of action against C. auris is differentiated from standard of care...

60 Degrees Pharmaceuticals to Sponsor Pre-Clinical Studies of Tafenoquine Use in Candida spp, Including Candida auris

To lead U.S. commercial relaunch of ARAKODA (tafenoquine) for malaria preventionWill support Company plan to expand clinical research strategy in tick-borne diseases beyond acute babesiosis...

60 Degrees Pharmaceuticals Appoints Kristen Landon as Chief Commercial Officer

WallachBeth Capital Announce Closing of 60 Degrees Pharmaceuticals $2.4 Million Public Offering WallachBeth Capital Announce Closing of 60 Degrees Pharmaceuticals $2.4 Million Public Offering PR...

WallachBeth Capital Announce Closing of 60 Degrees Pharmaceuticals $2.4 Million Public Offering

WASHINGTON, Jan. 31, 2024 (GLOBE NEWSWIRE) -- 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP; SXTPW) ( 60 Degrees Pharmaceuticals or the Company ), specialists in developing and marketing new...

60 Degrees Pharmaceuticals Announces Closing of $2.4 Million Public Offering

60 Degrees Pharmaceuticals, Inc. develops medicines for the treatment and prevention of infectious diseases. Its product Arakoda helps in the prevention of malaria. The company was founded by Geoffrey Dow on September 9, 2010 and is headquartered in Washington, DC.

Watchers	1,136
52-Wk Low	$0.2011
52-Wk High	$8.65

Volume	37,107.00
52-Wk High	$8.65
52-Wk Low	$0.2011

SXTP 60 Degrees Pharmaceuticals Inc

About

Feed

News

Fundamentals